Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of a PD-1 antagonist and a listeria-based vaccine for treating prostate cancer

Combination of a PD-1 antagonist and a listeria-based vaccine for treating prostate cancer

US Patent 9907849 · Granted Mar 6, 2018

Estimated economic value: $1,378,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for tumor immunotherapy2025
Immunogenic compositions targeting recurrent cancer mutations and methods of use2024
Listeria-based compositions comprising a peptide minigene expression system and 2023
Child-resistant single pill dispenser2022
Apparatus, system and method of providing a safety container2021
Listeria-based compositions comprising a peptide minigene expression system and 2021
Cartridge adjustment dial2020
Apparatus, system and method for a pill dispenser2020
Combination of a PD-1 antagonist and a VEGFR inhibitor for treating cancer2020
Combination of a PD-1 antagonist and a VEGFR inhibitor for treating cancer2020
Beverage additive cartridge cap2020
Apparatus, system and method of providing a safety container2019